{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:17:05Z","timestamp":1731043025260,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.7759\/cureus.51510","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:06:04Z","timestamp":1704200764000},"source":"Crossref","is-referenced-by-count":0,"title":["Navigating the Complexity of a Bipolar Pregnant Patient With Multiple Comorbidities"],"prefix":"10.7759","author":[{"given":"Paula","family":"Traugott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","year":"2022","key":"ref1","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing, Washington, DC; 2022."},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.4103\/ijp.ijp_407_21","article-title":"Pharmacological treatment of bipolar disorder in pregnancy: an update on safety considerations","volume":"54","author":"Singh S","year":"2022","unstructured":"Singh S, Deep R. Pharmacological treatment of bipolar disorder in pregnancy: an update on safety considerations. Indian J Pharmacol. 2022, 54:443-51.","journal-title":"Indian J Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109116","article-title":"Patients with psychogenic nonepileptic seizures and suspected epilepsy: an antiseizure medication reduction study","volume":"141","author":"Tavakoli Yaraki P","year":"2023","unstructured":"Tavakoli Yaraki P, Paredes-Aragon E, Joe Yu Y, AlKhateeb M, Mirsattari SM. Patients with psychogenic nonepileptic seizures and suspected epilepsy: an antiseizure medication reduction study. Epilepsy Behav. 2023, 141:109116. 10.1016\/j.yebeh.2023.109116","journal-title":"Epilepsy Behav"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64148-9.00011-9","article-title":"Epilepsy","volume":"174","author":"Bastos F","year":"2020","unstructured":"Bastos F, Cross JH. Epilepsy. Handb Clin Neurol. 2020, 174:137-58. 10.1016\/B978-0-444-64148-9.00011-9","journal-title":"Handb Clin Neurol"},{"key":"ref5","article-title":"Psychogenic Nonepileptic Seizures","author":"Huff JS","year":"2022","unstructured":"Huff JS, Murr N. Psychogenic Nonepileptic Seizures. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2019.7781","article-title":"Psychotropic treatment during pregnancy: research synthesis and clinical care principles","volume":"29","author":"Betcher HK","year":"2020","unstructured":"Betcher HK, Wisner KL. Psychotropic treatment during pregnancy: research synthesis and clinical care principles. J Womens Health (Larchmt). 2020, 29:310-8. 10.1089\/jwh.2019.7781","journal-title":"J Womens Health (Larchmt)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1041501","article-title":"Antipsychotic use in pregnancy","volume":"16","author":"Kulkarni J","year":"2015","unstructured":"Kulkarni J, Storch A, Baraniuk A, Gilbert H, Gavrilidis E, Worsley R. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015, 16:1335-45. 10.1517\/14656566.2015.1041501","journal-title":"Expert Opin Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13473","article-title":"Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: application to a pregnant woman and her neonate","volume":"16","author":"Mahdy WY","year":"2023","unstructured":"Mahdy WY, Yamamoto K, Ito T, et al.. Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: application to a pregnant woman and her neonate. Clin Transl Sci. 2023, 16:618-30. 10.1111\/cts.13473","journal-title":"Clin Transl Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40501-019-0165-5","article-title":"Use of antipsychotic drugs during pregnancy","volume":"6","author":"Betcher HK","year":"2019","unstructured":"Betcher HK, Montiel C, Clark CT. Use of antipsychotic drugs during pregnancy. Curr Treat Options Psychiatry. 2019, 6:17-31. 10.1007\/s40501-019-0165-5","journal-title":"Curr Treat Options Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.03.014","article-title":"Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis","volume":"269","author":"Bais B","year":"2020","unstructured":"Bais B, Molenaar NM, Bijma HH, et al.. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis. J Affect Disord. 2020, 269:18-27. 10.1016\/j.jad.2020.03.014","journal-title":"J Affect Disord"},{"key":"ref11","article-title":"Clozapine","author":"Haidary HA","year":"2021","unstructured":"Haidary HA, Padhy RK. Clozapine. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05542-2","article-title":"Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?","volume":"43","author":"Mari L","year":"2022","unstructured":"Mari L, Placidi F, Romigi A, et al.. Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?. Neurol Sci. 2022, 43:1993-2001. 10.1007\/s10072-021-05542-2","journal-title":"Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001056","article-title":"Epilepsy and pregnancy","volume":"28","author":"Li Y","year":"2022","unstructured":"Li Y, Meador KJ. Epilepsy and pregnancy. Continuum (Minneap Minn). 2022, 28:34-54. 10.1212\/CON.0000000000001056","journal-title":"Continuum (Minneap Minn)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-018-0996-7","article-title":"Fetal safety of levetiracetam use during pregnancy","volume":"118","author":"Koc G","year":"2018","unstructured":"Koc G, Keskin Guler S, Karadas O, Yoldas T, Gokcil Z. Fetal safety of levetiracetam use during pregnancy. Acta Neurol Belg. 2018, 118:503-8. 10.1007\/s13760-018-0996-7","journal-title":"Acta Neurol Belg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108253","article-title":"Lacosamide serum concentrations during pregnancy","volume":"123","author":"Zutshi D","year":"2021","unstructured":"Zutshi D, Millis SR, Basha MM, Daimee MA, Srinivas M. Lacosamide serum concentrations during pregnancy. Epilepsy Behav. 2021, 123:108253. 10.1016\/j.yebeh.2021.108253","journal-title":"Epilepsy Behav"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-019-00601-8","article-title":"Is therapeutic drug monitoring of lacosamide needed in patients with seizures and epilepsy?","volume":"45","author":"Schultz L","year":"2020","unstructured":"Schultz L, Mahmoud SH. Is therapeutic drug monitoring of lacosamide needed in patients with seizures and epilepsy?. Eur J Drug Metab Pharmacokinet. 2020, 45:315-49. 10.1007\/s13318-019-00601-8","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2009.05.024","article-title":"Pregnancy outcomes for women with epilepsy and bipolar disorder could be improved with intraventricular or intrathecal medication administration","volume":"73","author":"Alisky JM","year":"2009","unstructured":"Alisky JM. Pregnancy outcomes for women with epilepsy and bipolar disorder could be improved with intraventricular or intrathecal medication administration. Med Hypotheses. 2009, 73:1073-4. 10.1016\/j.mehy.2009.05.024","journal-title":"Med Hypotheses"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-0708-z","article-title":"Marijuana: the effects on pregnancy, the fetus, and the newborn","volume":"40","author":"Martin GI","year":"2020","unstructured":"Martin GI. Marijuana: the effects on pregnancy, the fetus, and the newborn. J Perinatol. 2020, 40:1470-6. 10.1038\/s41372-020-0708-z","journal-title":"J Perinatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000685","article-title":"Marijuana use in pregnancy: a review","volume":"74","author":"Thompson R","year":"2019","unstructured":"Thompson R, DeJong K, Lo J. Marijuana use in pregnancy: a review. Obstet Gynecol Surv. 2019, 74:415-28. 10.1097\/OGX.0000000000000685","journal-title":"Obstet Gynecol Surv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000418","article-title":"Stimulant use in pregnancy: an under-recognized epidemic among pregnant women","volume":"62","author":"Smid MC","year":"2019","unstructured":"Smid MC, Metz TD, Gordon AJ. Stimulant use in pregnancy: an under-recognized epidemic among pregnant women. Clin Obstet Gynecol. 2019, 62:168-84. 10.1097\/GRF.0000000000000418","journal-title":"Clin Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/212700-navigating-the-complexity-of-a-bipolar-pregnant-patient-with-multiple-comorbidities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T07:05:15Z","timestamp":1730963115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/212700-navigating-the-complexity-of-a-bipolar-pregnant-patient-with-multiple-comorbidities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.51510","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2024,1,2]]}}}